Get started
Author

Anita L. Bane

Observed names: A Bane, A. Bane, A. L Bane, A. L. Bane, A.L. Bane, Anita Bane, Anita L Bane, Bane, Anita
Observed institutions: BC Cancer Agency, Mount Sinai Hospital, Cancer Prevention Institute of California, Mount Sinai Hospital, University Health Network, Karolinska University Hospital, University of British Columbia, University of Ottawa, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Cancer Care Ontario, Juravinski Cancer Centre, Peter MacCallum Cancer Centre, Juravinski Hospital, Toronto General Hospital, Princess Margaret Cancer Centre, Tallaght University Hospital, Karolinska Institutet, Mount Sinai Hospital, Mount Sinai Hospital, Centre François Baclesse, Cambridge Memorial Hospital, St. James's Hospital, Hamilton Health Sciences, Pomeranian Medical University, McMaster University
OpenAlex ID: A5014049385
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
2016 · Carsten Denkert, Stephan Wienert, et al. · Modern Pathology · 287
PDF
An international study to increase concordance in Ki67 scoring
2015 · Mei-Yin C Polley, Samuel C Y Leung, et al. · Modern Pathology · 215
PDF
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer
2023 · Timothy J. Whelan, Sally Smith, et al. · New England Journal of Medicine · 179
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
2017 · Kay Dias, Anna Dvorkin-Gheva, et al. · PLoS ONE · 178
PDF
BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays
2006 · Anita L. Bane, Jeanne C. Beck, et al. · The American Journal of Surgical Pathology · 170
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration
2016 · Samuel C Y Leung, Torsten O Nielsen, et al. · npj Breast Cancer · 153
PDF
A role for the TGFβ-Par6 polarity pathway in breast cancer progression
2009 · Alicia M. Viloria-Petit, Laurent David, et al. · Proceedings of the National Academy of Sciences · 128
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
2014 · Amanda B Spurdle, Fergus J Couch, et al. · Breast Cancer Research · 123
PDF
BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50
2006 · Robert W. Haile, Duncan C. Thomas, et al. · Cancer Epidemiology Biomarkers & Prevention · 123
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
2019 · Manuel A. Ferreira, Eric R. Gamazon, et al. · Nature Communications · 122
PDF
A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
2012 · Robin M. Hallett, Anna Dvorkin-Gheva, et al. · Scientific Reports · 120
PDF
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
2016 · kConFab Investigators, Valentina Silvestri, et al. · Breast Cancer Research · 118
PDF
Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study
2005 · Teri A Longacre, Marguerite Ennis, et al. · Modern Pathology · 118
PDF
E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast
2005 · Teresa L Mastracci, Suzanna Tjan, et al. · Modern Pathology · 117
PDF
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration
2019 · Samuel C Y Leung, Torsten O Nielsen, et al. · Histopathology · 108
PDF
An update on apocrine lesions of the breast
2007 · F P O’Malley, A Bane · Histopathology · 103
PDF
Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy
2014 · A.L. Bane, T.J. Whelan, et al. · Annals of Oncology · 100
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
2018 · David L. Rimm, Samuel C.Y. Leung, et al. · Modern Pathology · 99
PDF
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
2017 · Mira M. Shenouda, Amy Gillgrass, et al. · Breast Cancer Research · 80
PDF
The Spectrum of Apocrine Lesions of the Breast
2004 · F. P O???Malley, A. L Bane · Advances in Anatomic Pathology · 76
Invasive lobular carcinoma: to grade or not to grade
2004 · Anita L Bane, Susanna Tjan, et al. · Modern Pathology · 68
PDF
Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion
2015 · Diane Ojo, Fengxiang Wei, et al. · Current Medicinal Chemistry · 62
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
2008 · Anita L. Bane, Dushanthi Pinnaduwage, et al. · Breast Cancer Research and Treatment · 57
PDF
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
2018 · Lieske H Schrijver, Håkan Olsson, et al. · JNCI Cancer Spectrum · 56
PDF
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
2017 · William D. Gwynne, Robin M. Hallett, et al. · Oncotarget · 54
Works count: 76
Citation count: 3,608
H-index: 32
I10-index: 45
Year
Topic
Type